These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2006-005711-10||A double-blind, randomised, two-period crossover study to evaluate the hypnotic effects and safety of sublingual zolpidem for the treatment of insomnia.||bad-data|
|Not reported||2006-006726-26||An open-label randomised observer-blind study to evaluate 24-hour intragastric pH profile at day 1 and day 14 during treatment with a fixed combination of a histamine type 2 receptor antagonist and a ...||2007-11-27||due-trials|
|Not reported||2008-001179-30||A double-blind, randomized, placebo-controlled, cross-over, allergen challenge study to evaluate the efficacy, safety and tolerability of BLX-028914 in subjects with allergic rhinitis||2008-12-18||due-trials|
|Not reported||2010-020239-38||Conversion of fast acting oral opioids to Abstral (SL fentanyl) in opioid tolerant cancer patients with breakthrough pain.||2012-05-09||due-trials|
|Exempt||2011-001325-25||A phase I study to assess the pharmacokinetic profile of sublingual OX27 tablets in single and repeated doses in healthy subjects||2011-07-11||not-yet-due|
|Listed as ongoing, but also has a completion date and reported results||2011-001903-10||A randomized, double-blind, placebo-controlled, dose finding trial using sublingual alfentanil to alleviate pain associated with a prostate biopsy procedure||2013-06-04||bad-data|